VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,418,500 | +39.7% | 350,000 | +56.3% | 0.03% | +35.0% |
| Q2 2023 | $6,744,158 | -82.6% | 223,984 | -81.3% | 0.02% | -83.3% |
| Q1 2023 | $38,820,000 | +1254.5% | 1,200,000 | +1100.0% | 0.12% | +1100.0% |
| Q4 2022 | $2,866,000 | +742.9% | 100,000 | +900.0% | 0.01% | +400.0% |
| Q2 2021 | $340,000 | -96.8% | 10,000 | -98.0% | 0.00% | -96.1% |
| Q4 2018 | $10,545,000 | -9.3% | 500,000 | 0.0% | 0.05% | +2.0% |
| Q4 2017 | $11,620,000 | +1.2% | 500,000 | 0.0% | 0.05% | -2.0% |
| Q3 2017 | $11,480,000 | -50.5% | 500,000 | -52.4% | 0.05% | -60.8% |
| Q2 2017 | $23,184,000 | -3.2% | 1,050,000 | 0.0% | 0.13% | -2.3% |
| Q1 2017 | $23,951,000 | +9.0% | 1,050,000 | 0.0% | 0.13% | -13.6% |
| Q4 2016 | $21,966,000 | +428.4% | 1,050,000 | +600.0% | 0.15% | +450.0% |
| Q2 2016 | $4,157,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |